Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $101.91 billion. The enterprise value is $118.93 billion.
Market Cap | 101.91B |
Enterprise Value | 118.93B |
Important Dates
The next estimated earnings date is Tuesday, August 20, 2024, before market open.
Earnings Date | Aug 20, 2024 |
Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -0.20% in one year.
Shares Outstanding | 1.28B |
Shares Change (YoY) | -0.20% |
Shares Change (QoQ) | -0.61% |
Owned by Insiders (%) | 0.11% |
Owned by Institutions (%) | 88.57% |
Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 28.80 and the forward PE ratio is 14.87. Medtronic's PEG ratio is 1.52.
PE Ratio | 28.80 |
Forward PE | 14.87 |
PS Ratio | 3.15 |
Forward PS | 3.07 |
PB Ratio | 2.03 |
P/FCF Ratio | 19.60 |
PEG Ratio | 1.52 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.55, with an EV/FCF ratio of 22.87.
EV / Earnings | 32.35 |
EV / Sales | 3.67 |
EV / EBITDA | 14.55 |
EV / EBIT | 21.51 |
EV / FCF | 22.87 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.50.
Current Ratio | 2.03 |
Quick Ratio | 1.31 |
Debt / Equity | 0.50 |
Debt / EBITDA | 3.06 |
Debt / FCF | 4.81 |
Interest Coverage | 7.69 |
Financial Efficiency
Return on equity (ROE) is 7.20% and return on invested capital (ROIC) is 5.23%.
Return on Equity (ROE) | 7.20% |
Return on Assets (ROA) | 4.10% |
Return on Capital (ROIC) | 5.23% |
Revenue Per Employee | $340,674 |
Profits Per Employee | $38,695 |
Employee Count | 95,000 |
Asset Turnover | 0.36 |
Inventory Turnover | 2.13 |
Taxes
In the past 12 months, Medtronic has paid $1.13 billion in taxes.
Income Tax | 1.13B |
Effective Tax Rate | 23.56% |
Stock Price Statistics
The stock price has decreased by -7.71% in the last 52 weeks. The beta is 0.83, so Medtronic's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | -7.71% |
50-Day Moving Average | 81.08 |
200-Day Moving Average | 80.94 |
Relative Strength Index (RSI) | 50.22 |
Average Volume (20 Days) | 6,830,373 |
Short Selling Information
The latest short interest is 15.22 million, so 1.19% of the outstanding shares have been sold short.
Short Interest | 15.22M |
Short Previous Month | 13.32M |
Short % of Shares Out | 1.19% |
Short % of Float | 1.19% |
Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, Medtronic had revenue of $32.36 billion and earned $3.68 billion in profits. Earnings per share was $2.76.
Revenue | 32.36B |
Gross Profit | 21.15B |
Operating Income | 5.15B |
Pretax Income | 4.81B |
Net Income | 3.68B |
EBITDA | 8.18B |
EBIT | 5.53B |
Earnings Per Share (EPS) | $2.76 |
Balance Sheet
The company has $8.01 billion in cash and $25.02 billion in debt, giving a net cash position of -$17.02 billion or -$13.27 per share.
Cash & Cash Equivalents | 8.01B |
Total Debt | 25.02B |
Net Cash | -17.02B |
Net Cash Per Share | -$13.27 |
Equity (Book Value) | 50.21B |
Book Value Per Share | 39.16 |
Working Capital | 11.15B |
Cash Flow
In the last 12 months, operating cash flow was $6.79 billion and capital expenditures -$1.59 billion, giving a free cash flow of $5.20 billion.
Operating Cash Flow | 6.79B |
Capital Expenditures | -1.59B |
Free Cash Flow | 5.20B |
FCF Per Share | $3.92 |
Margins
Gross margin is 65.34%, with operating and profit margins of 15.90% and 11.36%.
Gross Margin | 65.34% |
Operating Margin | 15.90% |
Pretax Margin | 14.86% |
Profit Margin | 11.36% |
EBITDA Margin | 25.26% |
EBIT Margin | 17.08% |
FCF Margin | 16.07% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.52%.
Dividend Per Share | $2.80 |
Dividend Yield | 3.52% |
Dividend Growth (YoY) | 1.47% |
Years of Dividend Growth | 48 |
Payout Ratio | 101.45% |
Buyback Yield | 0.20% |
Shareholder Yield | 3.72% |
Earnings Yield | 3.61% |
FCF Yield | 5.10% |
Analyst Forecast
The average price target for Medtronic is $90.82, which is 14.27% higher than the current price. The consensus rating is "Hold".
Price Target | $90.82 |
Price Target Difference | 14.27% |
Analyst Consensus | Hold |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 4.85% |
EPS Growth Forecast (5Y) | 22.00% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
Last Split Date | Sep 27, 1999 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.73 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.73 |
Piotroski F-Score | 7 |